- IN₹7.98bn
- IN₹7.44bn
- IN₹7.72bn
Annual balance sheet for Anuh Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 253 | 531 | 623 | 734 | 541 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,408 | 1,756 | 1,931 | 2,262 | 2,395 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,587 | 3,076 | 3,362 | 3,762 | 4,513 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 613 | 527 | 492 | 584 | 561 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,472 | 4,050 | 4,457 | 5,066 | 5,574 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,309 | 1,613 | 1,527 | 1,785 | 2,030 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,334 | 1,638 | 1,545 | 1,806 | 2,051 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,138 | 2,412 | 2,912 | 3,260 | 3,522 |
| Total Liabilities & Shareholders' Equity | 3,472 | 4,050 | 4,457 | 5,066 | 5,574 |
| Total Common Shares Outstanding |